United States · FDA National Drug Code directory
Topiramate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68382-358_2535bcc8-fac7-4b15-8c6f-fd6675655fd3
- Product NDC
- 68382-358
- Form
- CAPSULE, EXTENDED RELEASE
- Composition / generic term
- Topiramate
- Labeler
- Zydus Pharmaceuticals USA Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20231113
- Source listing expiry
- 20271231
Source-listed ingredients
- TOPIRAMATE — 200 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68382-358-01) · 68382-358-01
- 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68382-358-05) · 68382-358-05
- 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68382-358-06) · 68382-358-06
- 3 BLISTER PACK in 1 CARTON (68382-358-78) / 10 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (68382-358-30) · 68382-358-78
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →